קלופידקסל 75

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

CLOPIDOGREL AS BESYLATE 75 MG

제공처:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC 코드:

B01AC04

약제 형태:

FILM COATED TABLETS

관리 경로:

PER OS

Manufactured by:

PHARMATHEN S.A., GREECE

치료 그룹:

CLOPIDOGREL

치료 징후:

Clopidogrel is indicated for the prevention of atherothrombotic events as follows:• Recent MI, Recent stroke or Established peripheral arterial disease: Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. For patients with a history of recent myocardial infarction (MI), recent stroke or established peripheral arterial disease, Clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not), new MI (fatal or not) and other vascular death.• Acute coronary syndrome: For patients with acute coronary syndrome (Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave MI) or ST segment elevation acute myocardial infarction), in combination with ASA in medically treated patients eligible for thrombolytic therapy, and those who are to be managed with percutaneous coronary intervention (with or without stent) or CABG clopi

승인 날짜:

2010-09-01